Benzinga’s Top Pre-Market NASDAQ Gainers (OREX, CRME, MPEL, ASYS)

Orexigen Therapeutics Inc (NASDAQ: OREX) rose 18.52% to $5.44 in the pre-market session. OREX has signed a licensing deal with the Japan's Takeda Pharmaceutical Co Ltd for the obesity drug, Contrave.

Cardiome Pharma Corporation (NASDAQ: CRME) added 13.89% to $7.05 in pre-market trading. CRME has achieved a US$30 million milestone from its collaboration and license agreement with Merck.

Melco Crown Entertainment Limited (NASDAQ: MPEL) moved up 4.35% to $4.08 in pre-market trading. MPEL’s quarterly revenue surged 165.80% y/y.

Amtech Systems Inc (NASDAQ: ASYS) gained 3.36% to $14.75 in the pre-market session. ASYS’s subsidiary Tempress Systems Inc has received new solar orders worth $37 million from numerous new and current customers in Asia.

Read more from Benzinga's Company news.